In addition, cytotoxic phenotype markers, such as granzyme B and Ki67, showed a trend towards upregulation in CD8 + T cells in the combination therapy group after stimulation with tumor cells ( online supplemental figure 5A ).
← all excerpts
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models.
1
—
—